Status:
UNKNOWN
Continuous Infusion of Palonosetron for Preventing of Postoperative Nausea and Vomiting
Lead Sponsor:
Incheon St.Mary's Hospital
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
FEMALE
20+ years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether continuous infusion of palonosetron after its prophylactic single injection can further reduce the incidence of postoperative nausea and vomiting in p...
Eligibility Criteria
Inclusion
- ASA Physical Status 1 or 2
- Elective gynaecological laparoscopic surgery of ≥ 1h duration
Exclusion
- Anti-emetics, steroids, or psychoactive medications within 24 h of study initiation
- Vomiting or retching in the 24 h preceding surgery
- Cancer chemotherapy within 4 weeks or emetogenic radiotherapy within 8 weeks before study entry
- Ongoing vomiting from gastrointestinal disease
Key Trial Info
Start Date :
March 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
132 Patients enrolled
Trial Details
Trial ID
NCT01482468
Start Date
March 1 2012
End Date
July 1 2012
Last Update
March 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Incheon St Mary's hospital
Incheon, South Korea, 403-720